Godspower Onukpousi: Department of Public Health, Lead City University, Ibadan, Nigeria
ORCID
Godspower Onukpousi 0009-0001-0139-190X
Despite substantial advancements in global antiretroviral scaling, Human Immunodeficiency Virus (HIV) remains a critical public health challenge in Nigeria. Holding the second-largest HIV burden in West and Central Africa, Nigeria possesses an estimated 1.9 million people living with HIV (PLHIV) and an adult prevalence rate of 1.3%. This paper reviews the contemporary epidemiological landscape of HIV in Nigeria, delineates its cellular pathophysiology, evaluates current biomedical and structural interventions—including Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP)—and highlights systemic barriers such as social stigma and financing constraints. By aligning data-driven interventions with the structural requirements of vulnerable subgroups, Nigeria can bridge implementation gaps and progress toward the UNAIDS 95-95-95 targets.
Keywords
This article is published under the Creative Commons Attribution 4.0 International License . Free to read, share, and adapt with attribution.
British Journal of Contemporary Research
Open Access · Peer Reviewed · Published by Bexford Publishing Ltd
Browse All Issues